AJP - Endocrinology and Metabolism, Vol 259, Issue 1 E1-10, Copyright © 1990 by American Physiological Society

ARTICLES

Peptide transport systems for opiates across the blood-brain barrier

W. A. Banks and A. J. Kastin
Veterans Administration Medical Center, New Orleans, Louisiana.

Opiate peptides administered on one side of the blood-brain barrier can exert powerful effects on processes occurring on the other side. There is evidence for direct passage of opiate peptides and their analogues across this barrier. Beta-Endorphin can enter the cerebrospinal fluid after systemic administration, but its entry into brain tissue has been more difficult to demonstrate, even though analogues enter at a modest rate. Enkephalins enter and exit the central nervous system as intact molecules by a combination of saturable and nonsaturable mechanisms. A family of transport systems may exist with varying affinities for the opiate enkephalins, antiopiates like tyrosine melanocyte-stimulating hormone inhibitory factor 1 (Tyr-MIF-1), and related peptides. The major system transporting these peptides, termed Peptide transport system 1, can be influenced by several factors with entry and exit rates affected by aging, drugs, amino acids, monoamines, aluminum, stress, and ethanol addiction and withdrawal. The homeostatic role of the blood-brain barrier thus extends to the regulation of the bidirectional transport of informational peptides such as the opiates.

This article has been cited by other articles:

				W. A. Banks The dam breaks: disruption of the blood-brain barrier in diabetes mellitus Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2595 - H2596. [Full Text] [PDF]

				M. Hauser, A. M. Donhardt, D. Barnes, F. Naider, and J. M. Becker Enkephalins Are Transported by a Novel Eukaryotic Peptide Uptake System J. Biol. Chem., February 4, 2000; 275(5): 3037 - 3041. [Abstract] [Full Text] [PDF]

				L.-I Tsao, B. Ladenheim, A. M. Andrews, C. C. Chiueh, J. L. Cadet, and T.-P. Su Delta Opioid Peptide [D-Ala2,D-leu5]Enkephalin Blocks the Long-term Loss of Dopamine Transporters Induced by Multiple Administrations of Methamphetamine: Involvement of Opioid Receptors and Reactive Oxygen Species J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 322 - 331. [Abstract] [Full Text]

				T. Kitazawa, T. Terasaki, H. Suzuki, A. Kakee, and Y. Sugiyama Efflux of Taurocholic Acid Across the Blood-Brain Barrier: Interaction with Cyclic Peptides J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 890 - 895. [Abstract] [Full Text]

				A. Fiori, P. Cardelli, L. Negri, M. R. Savi, R. Strom, and V. Erspamer Deltorphin transport across the blood-brain barrier PNAS, August 19, 1997; 94(17): 9469 - 9474. [Abstract] [Full Text] [PDF]

				J. Yu, E. R. Butelman, J. H. Woods, B. T. Chait, and M. J. Kreek Dynorphin A (1-8) Analog, E-2078, Crosses the Blood-Brain Barrier in Rhesus Monkeys J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 633 - 638. [Abstract] [Full Text]

				C. C. Taylor, D. Wu, Y. Soong, J. S. Yee, and H. H. Szeto Opioid Modulation of the Fetal Hypothalamic-Pituitary-Adrenal Axis: The Role of Receptor Subtypes and Route of Administration J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 129 - 135. [Abstract] [Full Text]